20450009: Ciprofloxacin hydrochloride (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Antibacterial\Quinolone antibacterial\Fluoroquinolone (substance)\Ciprofloxacin hydrochloride

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Anti-infective agent (substance)\Antibacterial\Quinolone antibacterial\Fluoroquinolone (substance)\Ciprofloxacin hydrochloride
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Quinoline\Quinolone (substance)\Quinolone antibacterial\Fluoroquinolone (substance)\Ciprofloxacin hydrochloride

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amine and/or amine derivative\Quinoline\Quinolone (substance)\Quinolone antibacterial\Fluoroquinolone (substance)\Ciprofloxacin hydrochloride

\Organic compound\Organic cyclic compound\Heterocyclic compound\Quinoline\Quinolone (substance)\Quinolone antibacterial\Fluoroquinolone (substance)\Ciprofloxacin hydrochloride
\Organic compound\Organic nitrogen compound\Amine and/or amine derivative\Quinoline\Quinolone (substance)\Quinolone antibacterial\Fluoroquinolone (substance)\Ciprofloxacin hydrochloride

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Ciprofloxacin hydrochloride	Is a	Product containing ciprofloxacin (medicinal product)	false	Inferred relationship	Some
Ciprofloxacin hydrochloride	Is a	Ciprofloxacin (substance)	false	Inferred relationship	Some
Ciprofloxacin hydrochloride	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Ciprofloxacin (substance)	true	Inferred relationship	Some
Ciprofloxacin hydrochloride	Is a	Quinolone antibacterial	false	Inferred relationship	Some
Ciprofloxacin hydrochloride	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Antibacterial (disposition)	true	Inferred relationship	Some
Ciprofloxacin hydrochloride	Is a	Fluoroquinolone (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
ciprofloxacinhydrochlorid 100 mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ciprofloxacin hydrochloride	Inferred relationship	Some
ciprofloxacinhydrochlorid 250 mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ciprofloxacin hydrochloride	Inferred relationship	Some
ciprofloxacinhydrochlorid 500 mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ciprofloxacin hydrochloride	Inferred relationship	Some
ciprofloxacinhydrochlorid 750 mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ciprofloxacin hydrochloride	Inferred relationship	Some
Ciprofloxacin (as ciprofloxacin hydrochloride) 3 mg/g eye ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ciprofloxacin hydrochloride	Inferred relationship	Some
Ciprofloxacin hydrochloride 0.3% solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ciprofloxacin hydrochloride	Inferred relationship	Some
Ciprofloxacin hydrochloride 3.5mg solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ciprofloxacin hydrochloride	Inferred relationship	Some
Ciprofloxacin hydrochloride + hydrocortisone 2.329mg/10mg suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ciprofloxacin hydrochloride	Inferred relationship	Some
ciprofloxacin 0,2 % + hydrocortison 1 % øreopløsning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ciprofloxacin hydrochloride	Inferred relationship	Some
ciprofloxacin + hydrocortison	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ciprofloxacin hydrochloride	Inferred relationship	Some
Ciprofloxacin hydrochloride + hydrocortisone 2.329mg/10mg suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ciprofloxacin hydrochloride	Inferred relationship	Some
Ciprofloxacin (as ciprofloxacin hydrochloride) 3 mg/mL eye drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ciprofloxacin hydrochloride	Inferred relationship	Some
ciprofloxacinhydrochlorid 100 mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ciprofloxacin hydrochloride	Inferred relationship	Some	1
ciprofloxacinhydrochlorid 100 mg tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Ciprofloxacin hydrochloride	Inferred relationship	Some	1
ciprofloxacinhydrochlorid 250 mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ciprofloxacin hydrochloride	Inferred relationship	Some	1
ciprofloxacinhydrochlorid 250 mg tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Ciprofloxacin hydrochloride	Inferred relationship	Some	1
ciprofloxacinhydrochlorid 500 mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ciprofloxacin hydrochloride	Inferred relationship	Some	1
ciprofloxacinhydrochlorid 500 mg tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Ciprofloxacin hydrochloride	Inferred relationship	Some	1
ciprofloxacinhydrochlorid 750 mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ciprofloxacin hydrochloride	Inferred relationship	Some	1
ciprofloxacinhydrochlorid 750 mg tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Ciprofloxacin hydrochloride	Inferred relationship	Some	1
ciprofloxacinhydrochlorid 100 mg tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Ciprofloxacin hydrochloride	Inferred relationship	Some	1
ciprofloxacinhydrochlorid 250 mg tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Ciprofloxacin hydrochloride	Inferred relationship	Some	1
ciprofloxacinhydrochlorid 500 mg tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Ciprofloxacin hydrochloride	Inferred relationship	Some	1
ciprofloxacinhydrochlorid 750 mg tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Ciprofloxacin hydrochloride	Inferred relationship	Some	1
Ciprofloxacin (as ciprofloxacin hydrochloride) 3 mg/mL eye drops	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Ciprofloxacin hydrochloride	Inferred relationship	Some	1
Ciprofloxacin (as ciprofloxacin hydrochloride) 750 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Ciprofloxacin hydrochloride	Inferred relationship	Some	1
Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 250 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Ciprofloxacin hydrochloride	Inferred relationship	Some	1
Ciprofloxacin (as ciprofloxacin hydrochloride) 500 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Ciprofloxacin hydrochloride	Inferred relationship	Some	1
Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 100 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Ciprofloxacin hydrochloride	Inferred relationship	Some	1
Ciprofloxacin (as ciprofloxacin hydrochloride) 3 mg/g eye ointment	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Ciprofloxacin hydrochloride	Inferred relationship	Some	1
ciprofloxacin 10 g/100 ml suspension	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Ciprofloxacin hydrochloride	Inferred relationship	Some	1
Ciprofloxacin (as ciprofloxacin hydrochloride) 3 mg/mL and dexamethasone 1 mg/mL ear suspension	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Ciprofloxacin hydrochloride	Inferred relationship	Some	2
Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 2 milligram/1 milliliter and hydrocortisone 10 milligram/1 milliliter conventional release ear suspension (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Ciprofloxacin hydrochloride	Inferred relationship	Some	1
Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 250 milligram and tinidazole 300 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Ciprofloxacin hydrochloride	Inferred relationship	Some	1
Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 25 milligram/1 milliliter conventional release oral suspension (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Ciprofloxacin hydrochloride	Inferred relationship	Some	1
Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 3 milligram/1 milliliter and fluocinolone acetonide 250 microgram/1 milliliter conventional release solution for ear drops (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Ciprofloxacin hydrochloride	Inferred relationship	Some	1
Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 3 milligram/1 milliliter conventional release solution for ear drops (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Ciprofloxacin hydrochloride	Inferred relationship	Some	1
Ciprofloxacin (as ciprofloxacin hydrochloride) 574.9 mg and ciprofloxacin 425.2 mg prolonged-release oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Ciprofloxacin hydrochloride	Inferred relationship	Some	1
Ciprofloxacin hydrochloride monohydrate (substance)	Is a	True	Ciprofloxacin hydrochloride	Inferred relationship	Some

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
34414017	Ciprofloxacin hydrochloride	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
34415016	Bay-Q 3939	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT core
34416015	Bay-o 9867 monohydrate	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT core
749600015	Ciprofloxacin hydrochloride (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
4841921000005111	ciprofloxacinhydrochlorid	da	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Danish module (core metadata concept)